Delonix Bioworks Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Delonix Bioworks General Information

Description

Developer of a biotechnology company designed to develop next-generation genetically engineered bacterial vaccines. The company's vaccine technology aims to provide solutions for antimicrobial-resistant infections by improving upon traditional vaccine research, enabling healthcare providers to deliver more effective treatments to patients.

Contact Information

Website
www.delonixbio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Building 11, Lane 388, Shengrong Road
  • Pudong New District
  • Shanghai
  • China
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Parent Company
CuroVax
Vertical(s)
Life Sciences
Corporate Office
  • Building 11, Lane 388, Shengrong Road
  • Pudong New District
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delonix Bioworks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Dec-2023 Completed Pre-Clinical Trials
1. Seed Round 10-Mar-2021 Completed Startup
To view Delonix Bioworks’s complete valuation and funding history, request access »

Delonix Bioworks Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delonix Bioworks Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
IDG Capital Venture Capital Minority
ZhenFund Venture Capital Minority
To view Delonix Bioworks’s complete investors history, request access »

Delonix Bioworks Investments (1)

Delonix Bioworks’s most recent deal was a Later Stage VC with CuroVax for . The deal was made on 01-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CuroVax 01-Jan-2024 Later Stage VC Biotechnology
To view Delonix Bioworks’s complete investments history, request access »

Ready to get started?

Request a free trial

Delonix Bioworks FAQs

  • When was Delonix Bioworks founded?

    Delonix Bioworks was founded in 2021.

  • Where is Delonix Bioworks headquartered?

    Delonix Bioworks is headquartered in Shanghai, China.

  • What is the size of Delonix Bioworks?

    Delonix Bioworks has 50 total employees.

  • What industry is Delonix Bioworks in?

    Delonix Bioworks’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Delonix Bioworks a private or public company?

    Delonix Bioworks is a Private company.

  • What is Delonix Bioworks’s current revenue?

    The current revenue for Delonix Bioworks is .

  • How much funding has Delonix Bioworks raised over time?

    Delonix Bioworks has raised $14M.

  • Who are Delonix Bioworks’s investors?

    Boehringer Ingelheim Venture Fund, IDG Capital, and ZhenFund have invested in Delonix Bioworks.

  • When was Delonix Bioworks acquired?

    Delonix Bioworks was acquired on 31-Dec-2023.

  • Who acquired Delonix Bioworks?

    Delonix Bioworks was acquired by CuroVax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process